Epilogen
Immuno-oncology company developing novel cancer immunotherapies using the IgE class of antibodies, which may offer advantages over traditional IgG antibodies in tumor targeting.
Investors
1
Categories
immuno-oncology, antibody-therapeutics, ige, oncology, biotech
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| AlbionVC (Healthcare) | London, UK | biotech-focused | seedseries-a+1 | 17 |